Sanctuary Advisors LLC Buys 49,064 Shares of Haleon plc (NYSE:HLN)

Sanctuary Advisors LLC grew its stake in Haleon plc (NYSE:HLN) by 25.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 245,310 shares of the company’s stock after acquiring an additional 49,064 shares during the quarter. Sanctuary Advisors LLC’s holdings in Haleon were worth $2,367,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HLN. Fortitude Family Office LLC acquired a new position in shares of Haleon in the 3rd quarter valued at approximately $28,000. Toronto Dominion Bank grew its position in shares of Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after purchasing an additional 3,470 shares during the period. Cultivar Capital Inc. acquired a new position in shares of Haleon in the 2nd quarter valued at approximately $40,000. Prospera Private Wealth LLC acquired a new position in shares of Haleon in the 3rd quarter valued at approximately $57,000. Finally, BOKF NA grew its position in shares of Haleon by 68.8% in the 2nd quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after purchasing an additional 2,842 shares during the period. 6.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on HLN. Morgan Stanley boosted their price objective on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research report on Friday, September 20th. UBS Group raised Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $10.95.

Haleon Trading Up 2.1 %

NYSE:HLN opened at $9.93 on Wednesday. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The business has a 50 day moving average price of $9.74 and a two-hundred day moving average price of $9.54. The company has a market cap of $44.93 billion, a P/E ratio of 29.19, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.